Haemophilia: Medical Treatments

(asked on 26th September 2019) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that the supply of factor concentrates for haemophiliacs will not be affected in the event that the UK leaves the EU without a deal.


Answered by
Edward Argar Portrait
Edward Argar
Minister of State (Ministry of Justice)
This question was answered on 2nd October 2019

The Department is doing everything appropriate to prepare for the United Kingdom’s exit from the European Union. We want to reassure patients that our plans should ensure the supply of medicines and medical products, including those used in the treatment of haemophilia, when we leave the EU on 31 October.

The Department, in partnership with the devolved administrations, has been working with trade bodies, product suppliers, and the health and care system across the UK to make detailed plans that should ensure continuation of the supply of medicines, to the whole of the UK and its Crown Dependencies.

On 26 June, we wrote to suppliers of medicines to the UK from or via the EU or European Economic Area setting out our continuing multi-layered approach to support continuity of supply of medicines and medical products from 31 October.

Further details can be found at the following link:

https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans

Ahead of 31 October, all necessary funding will be made available to support our preparations.

Reticulating Splines